Popular Trials
Phosphodiesterase type 5 inhibitor
Sildenafil for Erectile Dysfunction
Recruiting4 awardsPhase 4
Hartford, Connecticut
The purpose of this study is to determine if adding hyperbaric oxygen therapy, a therapy that delivers oxygen under slight pressure, to a drug treatment of PDE5I (such as Viagra, Levitra, Cialis)for men following surgery for prostate cancer will result in more men being able to continue to have erections.
Phosphodiesterase Type 5 (PDE5) Inhibitor
Sildenafil Cream for Female Sexual Arousal Disorder
Recruiting2 awardsPhase 2
Mobile, Alabama
This trial aims to help women with Female Sexual Arousal Disorder by using a cream or gel with Sildenafil applied directly to the genital area. This method hopes to improve sexual arousal while reducing side effects by targeting the treatment locally. Sildenafil, originally used to treat male erectile dysfunction, has been studied for its potential benefits in treating female sexual arousal disorder (FSAD).
Popular Filters
Phase 3 Trials
Phosphodiesterase-5 Inhibitor
Sildenafil for Pulmonary Hypertension
Recruiting3 awardsPhase 3
Hartford, Connecticut
This protocol describes a 2-arm randomized controlled pilot study assessing the tolerance, safety and efficacy of sildenafil compared to control. The hypothesis is that sildenafil will be well tolerated and efficacious in patients with chronic heart failure (NYHA class II and III) with evidence of systolic dysfunction (EF ≤40 %) and secondary pulmonary hypertension (SPAP \>40mmHg). Patients that satisfy the inclusion criteria will be randomized to sildenafil (40mg x 3) or placebo therapy for 6 months in a 2:1 blinded fashion. The placebo group will be compared to the active therapy group and analyzed for differences in the main study end-points Patient Global Assessment and 6-Minute Walk Test. The study will also assess safety, tolerability, symptoms and quality of life.
Phosphodiesterase type 5 (PDE5) inhibitor
Sildenafil Oral Film for Erectile Dysfunction
Recruiting1 awardPhase 3
Foley, Alabama
"This trial will test the effectiveness and safety of different doses of Sildenafil oral film compared to a placebo in around 488 men with erectile dysfunction. It is a large study required by the FDA to see
Trials With No Placebo
Phosphodiesterase Type 5 (PDE5) Inhibitor
Sildenafil for Choroidal Ischemia
Recruiting1 awardPhase 2
New York, New York
This trial is testing if Sildenafil can help patients with certain eye conditions by improving blood flow in the eye. The goal is to slow down vision loss and reduce the need for frequent treatments. Sildenafil, commonly known as Viagra, is primarily used to treat erectile dysfunction but has been studied for its effects on ocular blood flow and potential neuroprotective benefits in various eye conditions.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.